What is the CVR number of Perfusion Tech ApS?

Perfusion Tech ApS is registered with CVR / Virk under CVR 38238213.

What is the gross profit of Perfusion Tech ApS?

Perfusion Tech ApS reported a gross profit of -DKK 6.1m in 2025.

Perfusion Tech ApS employs 6 people as of the latest annual report.

Perfusion Tech ApS's registered address is Viborggade 70D, 1..

APSActiveAdvertising protection

Actively employed in the business

Name	Role	Member since
Current (1)
DC Declan Cassells Management	Management	2025

Former (2)


MA Mads Aagaard Linde Madsen Chief Executive Officer	Chief Executive Officer	2016 – 2023
PC Pernille Charlotte Singer Chief Executive Officer	Chief Executive Officer	2023 – 2025

Non-executive oversight

Name	Role	Member since
Current (1)
DC Declan Cassells Board of Directors	Board of Directors	2023

Former (8)


SS Sten Scheibye Board of Directors	Board of Directors	2022 – 2025
HC Henrik Christensen Chairman	Chairman	2023 – 2025
SB Steffen Boutrup Møller Board of Directors	Board of Directors	2017 – 2020
LH Lars Henning Stigel Board of Directors	Board of Directors	2020 – 2023
MA Mads Aagaard Linde Madsen Board of Directors	Board of Directors	2024 – 2025
JØ Jeppe Øvli Øvlesen Board of Directors	Board of Directors	2017 – 2025
TE Thomas Engelbrecht Nordkild Jonassen Board of Directors	Board of Directors	2017 – 2025
MA Morten Asp Vonsild Lund Chairman	Chairman	2017 – 2023

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Renew Pharmaceuticals Limited	Company	100%	100%	2025
Uddannelses- og Forskningsstyrelsen	Company	5–9.99%	5–9.99%	2023
ASBA CONSULTING ApS	Company	15–19.99%	15–19.99%	2016
TJ BIOTECH HOLDING ApS	Company	10–14.99%	10–14.99%	2019
M.T. Lund Holdings ApS	Company	10–14.99%	10–14.99%	2024
MHAaM Holdings ApS	Company	10–14.99%	10–14.99%	2024
QUANTASS ApS	Company	10–14.99%	10–14.99%	2019
TJ Biotech Holding ApS	Company	5–9.99%	5–9.99%	2023
Quantass ApS	Company	5–9.99%	5–9.99%	2024

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.